PPT-NOVEMBER 29, 2018 Managing Chronic Pain and Addiction in Individuals with Serious Illness

NOVEMBER 29 2018 Managing Chronic Pain and Addiction in Individuals with Serious Illness JESSICA S MERLIN MD PHD ASSOCIATE PROFESSOR OF MEDICINE DIVISION OF GENERAL INTERNAL MEDICINE SECTION OF PALLIATIVE CARE AND MEDICAL ETHICS. Edward Jouney, DO. Department of Psychiatry. Does this sound familiar? . “. My pain is 10/10, I’m anxious, and I need you to increase my morphine, because it’s not working.”. “I’m not sleeping because of the pain. Xanax is the only thing that helps me sleep. I think if you give me Xanax, we can come down on the methadone.”. Everyone on controlled substances is, however, at increased risk of addition.. ADDICTION VERSUS . DEPENDENCE. Physical dependence. …is manifested as a characteristic set of withdrawal signs and symptoms that emerge on reduction or complete cessation of use of an active compound.. Quiz Questions. 1. Many people imagine that a life without pain is desirable. Evidence from people with chronic pain insensitivity indicate that. a. those people are correct. . b. pain insensitivity is a disadvantage for children but an advantage for adults. . Trapped on High Dose Opioids. 2017 Conference on Pain. February 7, 2017. Novi, Michigan. Mark A. Weiner, MD. Section Head of Addiction Medicine . Medical Director of Substance Use Disorders. St. Joseph Mercy Hospital – Ann Arbor. Project Echo. June 21, 2018. The Team. Addiction team:. Paula Cook MD. Elizabeth Howell MD. Addiction Psychiatry and Medicine Fellows: Lauren . Prest. DO, David Crabtree MD and Patrick Bell MD. Tiffany Love PhD (Neuroscience). Management Strategies for Care Coordination. 16th Annual Case Management Conference:. Navigating the Future Course of Case Management. Tuesday, November 1, 2016 . Kellogg . Hotel & Conference Center. Department of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine 1 What is the Evidence for an Opioid-Sparing Effect of Cannabis? Assistant Professor Patrick H. Finan, Ph.D Dean Drosnes, MD, FASAM. Associate Medical Director. Director, Chronic Pain Treatment Program. Caron Treatment Centers. Disclosures. Name. Commercial Interests. Relevant Financial Relationships: What Was Received. Daniel P. Edney MD FACP. Objectives. Review common complications. Review CDC treatment guidelines. Review basic exit strategies. Common Complications. Tolerance. Dependency. Opioid Induced Hyperalgesia. Atlanta, GA. CDC, NACCHO, NaRCAD. April 10, 2019. Don . Teater MD, mph. TEATER HEALTH SOLUTIONS. 1. Disclosure. Neither I nor any members of my immediate family have a financial interest/arrangement or affiliation that could be perceived as a real or apparent conflict of interest related to the content or supporters of this activity.. “We . envision a society where people who are addicted to alcohol or other drugs, people in recovery from addiction, and people at-risk for addiction are valued and treated with dignity; and where stigma, accompanying attitudes, discrimination and other barriers to recovery are eliminated. We envision a society where addiction is recognized as a public health issue – a treatable disease for which individuals should seek and receive treatment; and where treatment is recognized as a specialized field of expertise” . Immersion Training in Addiction Medicine Programs 2021. May 2021. Daniel P. Alford, MD, MPH. Professor of Medicine. Associate Dean, Continuing Medical Education. Director, Clinical Addiction Research and Education (CARE) Unit. . Pain. An . Educational . Slide. . Set. American Society of Hematology . 2020 Guidelines . for . Management of . Venous . Thromboembolism. Slide . set. . authors:. Ahmar . U. . Zaidi, . MD, . Children’s . Treatment. Melissa Weimer, DO, MCR. Disclosures. Dr. Weimer is a consultant for . INFORMed. , IMPACT education, and the American Association of Addiction Psychiatry.. Dr. Weimer is the medical director of CODA, Inc..